Strengths
MilliporeSigma has a robust reputation for quality and reliability in the life sciences sector, which enhances customer trust.
The company has made significant investments in technology and infrastructure, including over €300 million in a new production site in Korea.
MilliporeSigma offers an extensive product portfolio that caters to various needs in pharmaceutical research and biopharmaceutical manufacturing.
The integration of services for contract development and manufacturing positions MilliporeSigma as a one-stop solution for clients.
The acquisition of Mirus Bio for $600 million has strengthened its capabilities in gene therapy manufacturing.
The company emphasizes high-quality biochemicals and organic chemicals, which are essential for scientific research.
MilliporeSigma's strong investment in state-of-the-art production facilities enhances its competitive edge in the market.
The brand is recognized as a trusted partner in scientific research and development, emphasizing quality, innovation, and comprehensive support.